CD99 and central nervous system cancer: This phenotype was associated with decreased Rac activity and increased Rho activity along with a significantly increased proportion of amoeboid cells to mesenchymal cells, suggesting the involvement of CD99 in amoeboid–mesenchymal transition in glioma migration [15].